The Evolution of Radionanotargeting Towards Clinical Precision Oncologya festschrift in honor of Kalevi Kairemo.

Contributor(s):

Jekunen, Antti

Material type: Text

text

Media type:

computer

Carrier type:

online resource

ISBN:

9781681088655

Subject(s):

Genre/Form:

Electronic Books.

LOC classification:

RC262 .E965 2022

Online resources:

Click to access digital title | log in using your CIU ID number and my.ciu.edu password.

Available additional physical forms:

Contents:

Tilte -- Copyright -- License -- Contents -- Foreword -- REFERENCES -- Preface -- List of Contributors -- Molecular Imaging in the Development of Antibody-Drug Conjugates -- Clare Senko1,2, Sze-Ting Lee1,2,4,5,*, Hui K. Gan1,3,4, Umbreen Hafeez1,3,4, Sagun Parakh1,3,4 and Andrew M. Scott1,2,4,5 -- INTRODUCTION -- ANTIBODY-DRUG CONJUGATES AS A CANCER THERAPEUTIC -- Design and Structure -- Mechanism of Action -- Clinical Development and Design -- Target Antigen Selection -- Antibody Selection -- Drug Payload -- Antibody-Drug Conjugation -- ROLE OF MOLECULAR IMAGING IN ADC DEVELOPMENT

Molecular Imaging in Clinical Development of ADCs -- ErbB2/HER2 -- EGFR -- TAG-72 -- CONCLUSION AND FUTURE DIRECTIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Preclinical Applications with Phage Display-derived Peptides -- Erkki Koivunen1,* -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Perspectives in 11C and 18F Radiochemistry -- Hugo Helbert1,2, Gert Luurtsema1, Rudi A.J.O. Dierckx1,*, Wiktor Szymanski2,3, Ben L. Feringa2 and Philip H. Elsinga1

11C -- EXPANDING THE TOOLBOX -- 18F -- TOWARDS ENHANCED BIOORTHOGONALITY -- OUTLOOK -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Introduction to Radionanotargeting in the 1990's: Dosimetry and Optimization of Antisense Oligonucleotide Radiotherapy in Vivo -- Antti Jekunen1,*, Mikko Tenhunen2 and Kalevi Kairemo3 -- INTRODUCTION -- Dose Calculation: From Macro to Micro -- DISCUSSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES

Subject: The Evolution of Radionanotargeting towards Clinical Precision Oncology is a remarkable book honoring Professor Kalevi Kairemo, who is known among academic and medical circles as a pioneer in novel radiolabeled therapeutics. This festschrift provides an overview of key advances in the field of radionanotargeting, and the directions for future development in patient care. Prof Kairemo's research is based on multiomics, which involves multiple elements: genomics, transcriptomics, proteomics, metabolomics, microbiomics, epigenomics, exposome, imaging, and precision medicine, which is reflected by.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	URL	Status	Date due	Barcode
Online Book (LOGIN USING YOUR MY CIU LOGIN AND PASSWORD)	G. Allen Fleece Library ONLINE	Non-fiction	RC262 (Browse shelf(Opens below))	Link to resource	Available		on1311341876

Description based upon print version of record.

880-01 Cover -- Tilte -- Copyright -- License -- Contents -- Foreword -- REFERENCES -- Preface -- List of Contributors -- Molecular Imaging in the Development of Antibody-Drug Conjugates -- Clare Senko1,2, Sze-Ting Lee1,2,4,5,*, Hui K. Gan1,3,4, Umbreen Hafeez1,3,4, Sagun Parakh1,3,4 and Andrew M. Scott1,2,4,5 -- INTRODUCTION -- ANTIBODY-DRUG CONJUGATES AS A CANCER THERAPEUTIC -- Design and Structure -- Mechanism of Action -- Clinical Development and Design -- Target Antigen Selection -- Antibody Selection -- Drug Payload -- Antibody-Drug Conjugation -- ROLE OF MOLECULAR IMAGING IN ADC DEVELOPMENT

Pre-clinical Studies of Molecular Imaging of ADCs -- Molecular Imaging in Clinical Development of ADCs -- ErbB2/HER2 -- EGFR -- TAG-72 -- CONCLUSION AND FUTURE DIRECTIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Preclinical Applications with Phage Display-derived Peptides -- Erkki Koivunen1,* -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Perspectives in 11C and 18F Radiochemistry -- Hugo Helbert1,2, Gert Luurtsema1, Rudi A.J.O. Dierckx1,*, Wiktor Szymanski2,3, Ben L. Feringa2 and Philip H. Elsinga1

INTRODUCTION -- 11C -- EXPANDING THE TOOLBOX -- 18F -- TOWARDS ENHANCED BIOORTHOGONALITY -- OUTLOOK -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Introduction to Radionanotargeting in the 1990's: Dosimetry and Optimization of Antisense Oligonucleotide Radiotherapy in Vivo -- Antti Jekunen1,*, Mikko Tenhunen2 and Kalevi Kairemo3 -- INTRODUCTION -- Dose Calculation: From Macro to Micro -- DISCUSSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES

DIAGNOSTICS OF PANCREATIC DUCTAL ADENOCARCINOMA WITH RADIOLABELLED NEUROTENSIN ANALOGUES: PRECLINICAL DATA.

The Evolution of Radionanotargeting towards Clinical Precision Oncology is a remarkable book honoring Professor Kalevi Kairemo, who is known among academic and medical circles as a pioneer in novel radiolabeled therapeutics. This festschrift provides an overview of key advances in the field of radionanotargeting, and the directions for future development in patient care. Prof Kairemo's research is based on multiomics, which involves multiple elements: genomics, transcriptomics, proteomics, metabolomics, microbiomics, epigenomics, exposome, imaging, and precision medicine, which is reflected by.

https://lib.ciu.edu/copyright-request-form

There are no comments on this title.

to post a comment.